Organic Active Ingredients TRIZ Cases

Nitrogen-substituted pyrimidine compounds inhibit mutant epidermal growth factor receptors to reduce dose-limiting toxicity from wild-type inhibition.

Measuring microRNA-150 expression levels identifies taxane-resistant ovarian cancer cells to guide targeted treatment strategies.

Segmented peptide amphiphiles boost retroviral transduction while ensuring rapid cellular degradation to prevent cytotoxicity.

Pseudozyma microorganisms produce mannosylerythritol lipid with specific fatty acid chains for industrial applications.

Optimized polysaccharides maintain viscosity under acidic conditions, creating a stable protective layer that extends symptom relief duration.

Enriching tetra, penta, and trimeric galacto-oligosaccharides while removing monosaccharides eliminates competing substrates to enhance bacterial colonization.

S-enantiomerically enriched oxprenolol compositions treat acute muscle weakness by isolating the active therapeutic enantiomer from racemic mixtures.

Oral 5-hydroxy-1-methylhydantoin prevents cancer recurrence by blocking carcinogenesis without the side effects of conventional therapies.

Amorphous propranolol ionic liquids reduce skin irritation by replacing crystalline free base formulations while maintaining transdermal flux.

A 2-methylene-19,21-dinorvitamin D3 analog binds vitamin D receptors to transport intestinal calcium.

Stable fumagillol carbamate polymorphs resolve self-condensation and hydrolysis issues during polymer conjugation.

Purified crocetinic acid targets pancreatic cancer stem cells by inhibiting the sonic hedgehog signaling pathway.

A nutraceutical composition combining Curcuma genus extract, alpha lipoic acid, and coenzyme Q10 to enhance sperm parameters.

Andrographolide reduces muscle-associated fibrosis by inhibiting CTGF, addressing severe side effects of glucocorticoid therapies.

TLR7/8 inhibitors block osteoclast differentiation, reducing bone resorption and physical impairment in chronic joint diseases.

A methylphenidate chewable tablet uses a barrier coated ion exchange resin complex to maintain extended release properties.

Combining NAMPT inhibitors with NAD precursors targets cancer cells while sparing normal tissue.

Hydration softens the polymer matrix, resolving rigidity gaps and improving comfort during wear.

High HLB emulsifiers create a self-emulsifying omega-3 system that ensures reliable absorption under fasting conditions.

Daurichromenic acid treats beta coronaviruses while avoiding central nervous system penetration.

2-Hydroxytetrahydrothienopyridine derivatives resist hydrolysis to achieve faster onset of action and reduced bleeding risks.

Complexing polynucleotides with 3E10 antibodies protects genetic cargo from nuclease degradation and reduces immunogenicity during in vivo delivery.

Conjugating 2H-pyrazolo[4,3-d]pyrimidine compounds to antibodies directs immune stimulation precisely to target cells.

Replacing folic acid with 5-methyl-(6S)-tetrahydrofolate in oral contraceptives prevents neural tube defects without masking vitamin B12 deficiency symptoms.

Combining GalNAc-conjugated oligonucleotides with oral TLR7 agonists suppresses HBV replication while activating innate immunity.

Targeting serum hyaluronan with specific inhibitors prevents inflammation and severe clinical outcomes in dengue fever.

Teclistamab-cqyv engages CD3 T cells to destroy BCMA-positive cancer cells in relapsed multiple myeloma patients.

Segmented Eudragit layers resolve pH variability contradictions to deliver stable drug release for inflammatory bowel disease treatment.

Hydroxypropyl-alpha-cyclodextrin clathrates modulate the phosphoinositide cycle to improve autophagy and reduce lysosomal stress without ototoxicity.

Monomeric modules penetrate cell membranes and undergo click chemistry to form high-affinity oligomers that inhibit toxic RNA repeats.

Allosteric FSHR antagonists suppress disease progression while minimizing bone mass loss, extending treatment duration beyond six months.

Thiazole-substituted aminopyrimidines inhibit spleen tyrosine kinase activity through localized molecular design.

Dendrimer formulations complexed with N-acetyl cysteine shift macrophages from M1 to M2 phenotypes, resolving inflammation without systemic side effects.

RIPK1 inhibitor compounds modulate inflammatory responses and cell death pathways to treat diseases associated with excessive inflammation.

Nanoparticle-assembled coacervates resolve diffusion instability by restricting macromolecular exchange to maintain spatiotemporal heterogeneity.

A transdermal cream combines cannabidiol and gamma amino butyric acid to deliver analgesic relief through the skin.

Pyrazolo[1,5-a]pyrazin-4-yl derivatives selectively inhibit TYK2 without interfering with JAK2-dependent signaling pathways.

Stable crystalline forms of a Bruton's Tyrosine Kinase inhibitor enable direct precipitation from reaction mixtures.

Viral delivery of p53 up-regulators reduces hepatic steatosis by resolving unclear links between p53 and lipid metabolism.

Aldose reductase inhibitors diminish acute respiratory distress syndrome severity by suppressing inflammatory responses and limiting viral replication.

FL118 formulation inhibits survivin and Mcl-1 to overcome treatment resistance in metastatic cancers.

A tricyclic sulfone compound modulates RORγt activity through a specific V-1 linker structure.

Nanoparticle compositions bind antibodies to carrier proteins via hydrophobic interactions to maintain therapeutic activity during lyophilization.

Natural extracts replace recombinant cytokines to mobilize stem cells without severe side effects.

Specific plasticizers reduce particle friction to maintain candesartan cilexetil polymorphic form I, preventing decomposition during formulation.

Mutated HIV-1 gp120 polypeptides induce Env trimers into specific conformations to overcome latent viral reservoirs.

Measuring VEGF-D and PlGF expression levels predicts patient responsiveness to targeted cancer therapies.

A tablet formulation of sporoderm-disrupted Ganoderma lucidum spores uses enzymatic extraction to enhance bioavailability.